<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0011420'>Death</z:hpo> receptors (DR) of the TNF family function as anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> immune effector molecules </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> cells, however, often exhibit DR-signaling resistance </plain></SENT>
<SENT sid="2" pm="."><plain>Previous studies indicate that radiation can modify gene expression within <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells and increase <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell sensitivity to immune attack </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this study is to investigate the synergistic effect of sub-lethal doses of ionizing radiation in sensitizing colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cells to <z:hpo ids='HP_0011420'>death</z:hpo> receptor-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODOLOGY/PRINCIPAL FINDINGS: The ability of radiation to modulate the expression of multiple <z:hpo ids='HP_0011420'>death</z:hpo> receptors (Fas/CD95, TRAILR1/DR4, TRAILR2/DR5, TNF-R1 and LTβR) was examined in <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> cells </plain></SENT>
<SENT sid="5" pm="."><plain>The functional significance of sub-lethal doses of radiation in enhancing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell susceptibility to DR-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was determined by in vitro functional sensitivity assays </plain></SENT>
<SENT sid="6" pm="."><plain>The longevity of these changes and the underlying molecular mechanism of irradiation in sensitizing diverse colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cells to <z:hpo ids='HP_0011420'>death</z:hpo> receptor-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> were also examined </plain></SENT>
<SENT sid="7" pm="."><plain>We found that radiation increased surface expression of Fas, DR4 and DR5 but not LTβR or TNF-R1 in these cells </plain></SENT>
<SENT sid="8" pm="."><plain>Increased expression of DRs was observed 2 days post-irradiation and remained elevated 7-days post irradiation </plain></SENT>
<SENT sid="9" pm="."><plain>Sub-lethal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell irradiation alone exhibited minimal cell <z:hpo ids='HP_0011420'>death</z:hpo>, but effectively sensitized three of three colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cells to both TRAIL and Fas-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, but not LTβR-induced <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Furthermore, radiation-enhanced Fas and TRAIL-induced cell <z:hpo ids='HP_0011420'>death</z:hpo> lasted as long as 5-days post-irradiation </plain></SENT>
<SENT sid="11" pm="."><plain>Specific analysis of intracellular sensitizers to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> indicated that while radiation did reduce Bcl-X(L) and c-FLIP protein expression, this reduction did not correlate with the radiation-enhanced sensitivity to Fas and/or TRAIL mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> among the three cell types </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS/SIGNIFICANCE: Irradiation of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells can overcome Fas and TRAIL resistance that is long lasting </plain></SENT>
<SENT sid="13" pm="."><plain>Overall, results of these investigations suggest that non-lethal doses of radiation can be used to make human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> more amenable to attack by anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> effector molecules and cells </plain></SENT>
</text></document>